Cardiovascular disease deaths involving concomitant hypertension increased in the US from 2000 to 2022, rising from 20% to 34.8% of CVD deaths in females and from 16.5% to 36.2% in males.
Despite declines in cardiovascular mortality without hypertension, cardiovascular deaths with concomitant hypertension have increased significantly in the US from 2000 to 2022, highlighting a growing public health challenge.
Tasa de eventos absoluta: 0% vs 0%
Objectives: Hypertension remains a persistent global challenge and is an essential risk factor for cardiovascular disease (CVD). However, the extent to which hypertension is implicated in CVD mortality in the United States remains unknown. We assessed CVD mortality trends with hypertension as a secondary cause (CVD-HTN) and the proportion of CVD mortality in those with and without secondary hypertension. Methods: We designed a sequential time-series analysis to examine trends in age-standardized mortality rates (18–84 years) with CVD as the underlying cause, with and without concomitant hypertension (as a secondary cause), in the United States from 2000 to 2022. We examined changes in CVD-HTN mortality rates (per 100 000 individuals). We assessed the proportionate fraction of CVD mortality in patients with and without hypertension as a secondary cause. Results: Among females, CVD-HTN mortality rates have increased from 47.4 in 2000 to 52.4 per 100 000 in 2022. CVD mortality rates without concomitant hypertension among females declined from 189.9 in 2000 to 98.0 per 100 000 in 2022. CVD-HTN mortality rates among males increased from 67.3 in 2000 to 96.2 per 100 000 in 2022. CVD mortality rates without concomitant hypertension among males declined over the same period (339.4 in 2000 to 169.9 per 100 000 in 2022). Among females in 2000 and 2022, 20 and 34.8% of CVD deaths were due to concomitant hypertension; among males, these estimates were 16.5 and 36.2%, respectively. Conclusion: The increase in CVD mortality associated with concomitant hypertension is concerning. Public health efforts to mitigate this increase may be worth considering.
Ananth et al. (Tue,) reported a other. Cardiovascular disease deaths involving concomitant hypertension increased in the US from 2000 to 2022, rising from 20% to 34.8% of CVD deaths in females and from 16.5% to 36.2% in males.